mediated isothermal amplification (RT-LAMP). These techniques were also validated using samples from ZIKV infected patients and mosquitoes.
INTRODUCTION AND OBJECTIVES: Within 4 weeks, 90%
of long-term catheterized patients will develop bacteriuria, and 50% will experience encrustation and marked elevation of urine pH. Urease-producing bacteria have been linked to elevated urine pH, catheter-associated urinary tract infection (CAUTI), encrustation, and struvite renal calculi. We propose a method to monitor alkalinization of urine as part of a multimodal system which could play a role in prevention of catheter encrustation. Reversibility of the colorimetric membrane acts as a form of biofeedback to allow for modification of oral intake with acidifying agents and control urine pH to prevent encrustation.
METHODS: To create a pH-sensitive, reversible colorimetric porous membrane with immediate detection of alkaline urine, high molecular weight polymer was solvated in organic solvent. A quaternary ammonium salt and indicator dye were then added for pH sensitivity and electrostatic retention of the dye. Addition of plasticizer followed to modify the membrane mechanical properties. This solvated mixture was stored under 4 C refrigeration until casting.
RESULTS: The solvated membrane blend was drop cast onto the inside of catheter tubing for demonstration. Basic solution (pH 7.5 / NaOH) was passed through and a distinct and visible change of color to green (see Figure 1 ) was observed upon exposure. Dilute acidic solution was then passed through (pH 4 / H 2 CO 3 ) and there was a rapid reversal (< 5 seconds) to original yellow color. The urinary pH range from 4.0 to 9.0 can be monitored by this system. CONCLUSIONS: The clear colorimetric indication afforded by this membrane provides a robust system for the reversible detection of real-time changes in urine pH. As a component of a multipart system, this provides rapid biofeedback that allows for informed and directed intervention. This system may also assist in the detection of elevated urine pH secondary to urease-producing bacteria responsible for encrustation and recurrent struvite kidney stone formation. INTRODUCTION AND OBJECTIVES: Urinary tract infections (UTI) are one of the most prevalent conditions worldwide, with incidence increasing with age. Oestrogen decrease in post-menopausal women lowers levels of Lactobacillus within the vaginal microenvironment, a key factor in synthesising lactic acid and the creation of the acidic vaginal defence. These women often require long-term antibiotics. However with the rising incidence of bacterial resistance, there is a need to find alternative therapies. FemTouch is a thermal ablative laser, which when applied to the vagina, induces a histologically proven rejuvenation of the lining to a pre-menopausal state, similar to oestrogen therapy. FemTouch is used by gynaecologists to treat atrophic vaginitis and is favourable in women unsuitable for oestrogen therapy. We present the first experience in the United Kingdom (UK) of using FemTouch to treat recurrent UTIs in a preliminary cohort of women.
Source of Funding
METHODS: 9 postmenopausal women with recurrent UTIs received 3 courses of FemTouch (Lumenis, Israel) at monthly intervals. Total follow up for 6 months assessed rates of UTI, changes in vaginal pH and assessment of vaginal health using subjective measures of vaginal fluid/moisture, firmness and elasticity. No patients received concurrent antibiotic or hormonal therapy during the treatment or follow up period.
RESULTS: Pre-treatment, the patients averaged one UTI every 6 weeks. To date only one patient has had a recurrence of UTI after treatment. The average vaginal pH, displayed in table 1, improved with treatment. All patients described marked improvements in menopausal vaginal symptoms, as shown by their average vaginal health scores in table 2. All patients described the pain of the procedure as 1/10 on average throughout.
CONCLUSIONS: Our preliminary results show that FemTouch is both effective and well tolerated in the treatment of recurrent UTIs in postmenopausal UK women, suggesting FemTouch may be a viable alternative to antibiotic prophylaxis. In addition, laser treatment made a big difference to patients general vaginal health, restoring it in the patients view to a pre-menopausal state. There seems to be enough merit to establish a national multi-centre trial to evaluate the efficacy of FemTouch in larger groups of patients for a longer follow up period.
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